Nucleotide metabolism and enzyme inhibitors in thymic acute lymphoblastic leukaemia.
D000243:Adenosine Deaminase / Q000378:metabolism; D058892:Adenosine Deaminase Inhibitors; D001402:B-Lymphocytes / Q000201:enzymology; D002460:Cell Line; D002470:Cell Survival; D002648:Child; D003070:Coformycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004253:DNA Nucleotidylexotransferase / Q000378:metabolism; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000378:metabolism*; D015649:Pentostatin; D011685:Purine Nucleotides / Q000378:metabolism*; D011683:Purine-Nucleoside Phosphorylase / Q000378:metabolism; D013601:T-Lymphocytes / Q000201:enzymology; D013953:Thymus Neoplasms / Q000201:enzymology*
D058892:Adenosine Deaminase Inhibitors; D011685:Purine Nucleotides; D003070:Coformycin; D015649:Pentostatin; D011683:Purine-Nucleoside Phosphorylase; D004253:DNA Nucleotidylexotransferase; D000243:Adenosine Deaminase